SmartNuclide®

技术应用

专注创新核医学诊疗药物研发与应用

Evaluation of SNA001, a Novel Recombinant Human Thyroid Stimulating Hormone Injection, in Patients With Differentiated Thyroid Carcinoma

2022年4月30日

Evaluation of SNA001, a Novel Recombinant Human Thyroid Stimulating Hormone Injection, in Patients With Differentiated Thyroid Carcinoma

Front. Endocrinol., 17 February 2021

https://doi.org/10.3389/fendo.2020.615883